Prev Close | 41.70 |
Day Low/High | 41.52 / 42.14 |
52 Wk Low/High | 38.20 / 58.83 |
Prev Close | 41.70 |
Day Low/High | 41.52 / 42.14 |
52 Wk Low/High | 38.20 / 58.83 |
Exchange | NYSE |
Shares Outstanding | 133.57B |
Market Cap | 5.57B |
P/E Ratio | N/A |
Div & Yield | N.A. (N.A) |
Get paid very well for making the 'uncomfortable' play others are afraid to take.
Everything about the CEO's move to Valeant stinks.
Trying to exploit the PRGO-VRX dealings could leave you with a losing hand.
Jim Cramer says there are still a lot of questions around Valeant, which named a new CEO, Joseph Papa today.
Valeant delighted shareholders Monday with news that Perrigo's Joseph Papa is getting into the driver's seat.
U.S. stocks opened lower Monday morning in a busy week for economic and earnings news.
Perrigo is in a CEO battle, while Bunge has undergone a quiet rise.
Wall Street is confident that Valeant can turn around its steep share price decline with the right successor as CEO.
Other companies have suffered following the debacle.
Other companies have suffered following the debacle.
The market went too far, too fast.
The Fed isn't the only one that can use facts in shaping decisions.
Its best entry points over the last nine years looked very similar to the company's current valuation.
Excitement surrounding 3D-technology appears to be paying off for Nvidia.
With biotech stocks getting smashed on the stock market and big pharma getting hammered on the presidential campaign trail, generic drug stocks look awfully appealing.
Stand-alone vitamin and supplement shops like GNC and Vitamin Shoppe shares will continue to fall in light of a Justice Department investigation.
These two will continue to churn out earnings growth.
Buying it here would be like trying to catch a falling knife.
Mylan (MYL) gained ground Tuesday after it announced plans to start a $27.1 billion hostile takeover of Perrigo (PRGO).
U.S. stocks opened lower Friday as personal income and spending both rose in July.
Deal flow has been massive in the first half of 2015 from healthcare to technology to insurance.
The Israeli economy is strong, growing fast and offers good value, according to William Scholes, investment manager for Aberdeen Asset management.
Deals coming fast and furious in the best group in town.
Acquisitions cut into overabundance of companies.
The Merger Fund seeks absolute returns and is not correlated to the stock market so it will fare well in a rising rate environment.
The surge in deal-making has created the ideal environment for merger arbitrage or event-driven funds, said K.C. Nelson, portfolio manager for the Driehaus Event Driven Fund.
The Nasdaq was the clear winner on markets Friday. The tech-heavy index spiked into record territory as Amazon (AMZN), Microsoft (MSFT) and Google (GOOGL) rallied after reporting earnings.